Developer docs
API playgroundTry for free, no card

Search company profiles

SkinIO

Full company profile

uuid0000v73

Namestring
SkinIO
Legal namestring
SkinIO, Inc.
Websiteurl
skinio.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

SkinIO, Inc. is a Chicago-based digital health company that has built an AI-powered, smartphone-based platform for skin cancer screening and longitudinal skin health monitoring. The core product is the SkinIO mobile app (iOS and Android), which guides users through a structured 10-minute photo-capture process covering approximately 90% of the body's surface. Captured images are encrypted, removed from the device, and uploaded to HIPAA-compliant cloud storage, where AI-driven computer vision and anomaly detection identify suspicious spots or changes (claimed sensitivity down to 1mm). Board-certified dermatologists then review the AI-assisted output and return medical recommendations within 2–3 days; a "Connection to Care" team fast-tracks patients needing in-person follow-up to in-network dermatologists within 2–3 weeks. Each scan feeds a longitudinal digital skin health record that supports change-over-time comparison.

The platform is delivered through two distinct go-to-market motions. On the consumer side, individuals purchase one-time screenings directly via the app at a $239 price point (with promotional pricing at $189). On the enterprise side, SkinIO sells into large self-funded employers, labor unions, and health systems as a preventive wellness benefit — named customers include MetroHealth System, a Chicago-based airline, Signature Custom Cabinetry, and Aspire Ventures, totaling approximately 90 customers nationwide. Enterprise distribution is being actively expanded through partnerships with Smart Health Innovation Lab, MSK Direct (Memorial Sloan Kettering's cancer care benefits network), and ACP's Employee Health & Wellness Conference in 2025, alongside a dermatology clinician-facing module for in-office augmentation.

SkinIO generates revenue from one-time consumer screening fees and recurring B2B subscription or per-employee contracts with enterprise customers. The company is venture-backed, having raised more than $6.5 million cumulatively from individual investors including Citadel founder Ken Griffin and former Walgreens executive Stewart Wasson, with disclosed funding rounds in 2015, 2019, and 2020. Headcount sits in the 11–50 range, with a three-person engineering team that maintains HIPAA expertise. The company competes in the global teledermatology market, valued at $16.71 billion in 2025 with a projected 16.72% CAGR through 2034, and the AI-powered tele-dermatology triage segment ($2.8 billion in 2025, projected to $9.4 billion by 2034).

Short descriptiontext

SkinIO is a Chicago-based health technology company offering AI-powered smartphone skin cancer screening with board-certified dermatologist review, serving individual consumers via a $239 mobile app and enterprises (employers, health systems, unions) as a workplace wellness benefit.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
skin cancer screening, teledermatology platform, AI skin imaging, employee wellness benefits, digital skin health record
Industry2 codes
PRIMARYHLALAGAA
Dermatology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAKACAA
General & Medical Dermatology
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
Product category
Teledermatology Software
Social media profiles4 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Direct-to-Consumer Screening
TypeOne Time License
Description

Individual consumers purchase one-time skin cancer screenings through the SkinIO app for $239. Each screening includes a full-body photo capture, dermatologist review, and results delivered in 2-3 days.

go.skinio.com
2Enterprise/B2B Employee Benefits
TypeSubscription Recurring
Description

SkinIO sells its screening platform as an employee health benefit to large employers, unions, and health systems (such as MetroHealth System). B2B contracts likely involve per-employee/per-screening pricing or subscription arrangements.

skinio.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1One-Time Skin Cancer Screening - $239
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Complete full-body skin cancer screening using smartphone. Includes AI-guided photo capture, board-certified dermatologist review, and results in 2-3 days. Fast-tracked to in-network dermatologists within 2-3 weeks if follow-up recommended.

go.skinio.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

SkinIO provides an AI-powered smartphone-based skin cancer screening platform that guides users through a 10-minute full-body photo capture, uploads images to a HIPAA-compliant cloud for review by board-certified dermatologists, and delivers medical recommendations in 2-3 days. The platform operates a direct-to-consumer mobile app at $239 per screening and also offers enterprise solutions for employers, unions, health systems, and clinicians, including a Connection to Care service that fast-tracks patients needing follow-up to in-network dermatologists within 2-3 weeks.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Detects changes in skin down to 1mm
+4 more records
Product overview1 text field

SkinIO is a health technology company offering an AI-powered skin cancer screening platform. The core offering consists of the SkinIO mobile app for consumer skin screening and the Connection to Care service for dermatologist referrals. The platform enables 10-minute smartphone-based full-body skin scans with board-certified dermatologist review delivered within 2-3 days. Enterprise offerings include dedicated solutions for employers, health systems, unions, and clinicians. The dermatologist-facing platform provides tools for image review, spot annotation, and longitudinal tracking. Priced at $239 per screening (with promotional pricing at $189 available).

Product and service7 records
1SkinIO Mobile App
CategoryCore Product
Description

Consumer-facing mobile application available on iOS and Android that enables individuals to complete a full-body skin cancer screening from home in 10 minutes using their smartphone. The app guides users through the photo-taking process and uploads images for board-certified dermatologist review.

2Connection to Care
CategoryCare Coordination Service
Description

Care coordination service that fast-tracks users whose SkinIO scan flags concerning findings to in-network dermatologists for in-person follow-up, with appointments typically scheduled within 2-3 weeks.

3SkinIO for Employers
CategoryEnterprise Solution
Description

Enterprise offering that provides large employers with SkinIO's skin cancer screening technology as an employee health benefit, aimed at controlling healthcare costs and improving workforce health outcomes through early detection.

4SkinIO for Health Systems
CategoryEnterprise Solution
Description

Healthcare system integration that enables hospitals and health systems to offer SkinIO's skin cancer screening technology to their patient populations as part of integrated care pathways.

5SkinIO for Clinicians
CategoryClinical Platform
Description

Dermatologist-facing clinical platform that allows clinicians to review patient-submitted skin images, annotate spots with notes and dermoscopic images, mark them as new, changed, or suspicious, and track changes over time across visits.

6SkinIO for Unions
CategoryEnterprise Solution
Description

Union benefit offering that provides union members with access to SkinIO's skin cancer screening services as part of their member health benefits package.

7SkinIO Web Application
CategoryWeb Platform
Description

Web-based platform that allows users to access their SkinIO accounts, review screening results, and manage their longitudinal digital skin health records through a browser.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-05-06
Description

SkinIO was featured in the Innovator Spotlight at MSK Direct Benefits Leaders' Summit in New York City, showcasing AI-powered skin cancer screening platform to benefits leaders from major employers.

Strategic tierMinorTypeOthersAnnounced on2025-04-14
Description

San Francisco-based nonprofit dedicated to empowering youth in underserved neighborhoods. SkinIO donated to support their mission, reflecting broader commitment to community wellbeing.

Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-03-02
Description

SkinIO participated in the ACP Employee Health & Wellness Conference, an exclusive event connecting top benefits executives with innovative healthcare solution providers.

4Smart Health Innovation Lab
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Smart Health Innovation Lab partnered with SkinIO to bring virtual skin cancer screenings to Lancaster County. SkinIO provides at-home and on-site skin cancer screenings to employees of Signature Custom Cabinetry and Aspire Ventures, an investor/founder of the Innovation Lab.

skinio.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

SkinVision is an Amsterdam-based AI-powered skin cancer detection app with regulatory clearances (CE-marked, TGA-approved). It is the closest direct competitor to SkinIO, offering smartphone-based skin lesion risk assessment with teledermatology follow-up pathways.

TypeDirect peer
Description

Miiskin offers a smartphone-based mole and skin tracking app with AI-assisted photo comparison and partner dermatologist review. It serves a similar consumer self-monitoring niche and shares SkinIO's longitudinal skin-photo record feature.

TypeDirect peer
Description

DermaSensor is an FDA-cleared (2024) handheld device that uses AI and spectroscopy to evaluate skin lesions for primary care clinicians. It addresses the same skin cancer early-detection problem as SkinIO but through a clinical device rather than a smartphone app, making it a direct competitor for clinician and health system channels.

TypeDirect peer
Description

FotoFinder ( FotoFinder Systems GmbH) is a German specialist in total body photography and AI-assisted mole mapping for dermatology clinics. It competes with SkinIO for dermatologist and health system accounts that need longitudinal skin imaging, though its deployment model is hardware-based clinical installs rather than consumer smartphones.

TypeBroad incumbent
Description

Canfield Scientific is a long-established US leader in dermatology imaging systems, including VECTRA total body photography and DermaGraphix software. It sells primarily to dermatology practices and competes with SkinIO at the clinician-facing end of the market with significantly more capital and installed base.

TypeDirect peer
Description

MetaOptima built the DermEngine platform for dermatology imaging and AI skin lesion analysis, used by clinics and teledermatology services. It overlaps with SkinIO's clinician and health system offerings and is a credible direct competitor in AI dermatology decision support.

TypeDirect peer
Description

First Derm operates an asynchronous teledermatology platform connecting users to board-certified dermatologists for image-based consultations. It targets a similar consumer and enterprise use case as SkinIO but uses a per-consultation ticket model rather than an annual screening subscription.

TypeBroad incumbent
Description

Teladoc is the largest US telehealth platform with broad specialty coverage and enterprise contracts that easily absorb dermatology. As a broad incumbent, it could bundle or build a competing skin screening offering, putting enterprise channel pressure on SkinIO's go-to-market.

TypeBroad incumbent
Description

Amwell is an enterprise telehealth platform serving health systems and health plans with multi-specialty virtual care. It competes with SkinIO at the health system channel level and has the capital to acquire or build a teledermatology offering at scale.

TypeEmerging player
Description

MoleScope by MetaOptima offers a smartphone-attachable dermatoscope with the DermEngine app for mole tracking and teledermatology. It overlaps meaningfully with SkinIO on consumer smartphone-based skin monitoring while adding a hardware component that targets more clinical mole-mapping use cases.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SkinIO

Teledermatology Softwareskinio.com

SkinIO is a Chicago-based health technology company offering AI-powered smartphone skin cancer screening with board-certified dermatologist review, serving individual consumers via a $239 mobile app and enterprises (employers, health systems, unions) as a workplace wellness benefit.

What SkinIO does

SkinIO, Inc. is a Chicago-based digital health company that has built an AI-powered, smartphone-based platform for skin cancer screening and longitudinal skin health monitoring. The core product is the SkinIO mobile app (iOS and Android), which guides users through a structured 10-minute photo-capture process covering approximately 90% of the body's surface. Captured images are encrypted, removed from the device, and uploaded to HIPAA-compliant cloud storage, where AI-driven computer vision and anomaly detection identify suspicious spots or changes (claimed sensitivity down to 1mm). Board-certified dermatologists then review the AI-assisted output and return medical recommendations within 2–3 days; a "Connection to Care" team fast-tracks patients needing in-person follow-up to in-network dermatologists within 2–3 weeks. Each scan feeds a longitudinal digital skin health record that supports change-over-time comparison.

The platform is delivered through two distinct go-to-market motions. On the consumer side, individuals purchase one-time screenings directly via the app at a $239 price point (with promotional pricing at $189). On the enterprise side, SkinIO sells into large self-funded employers, labor unions, and health systems as a preventive wellness benefit — named customers include MetroHealth System, a Chicago-based airline, Signature Custom Cabinetry, and Aspire Ventures, totaling approximately 90 customers nationwide. Enterprise distribution is being actively expanded through partnerships with Smart Health Innovation Lab, MSK Direct (Memorial Sloan Kettering's cancer care benefits network), and ACP's Employee Health & Wellness Conference in 2025, alongside a dermatology clinician-facing module for in-office augmentation.

SkinIO generates revenue from one-time consumer screening fees and recurring B2B subscription or per-employee contracts with enterprise customers. The company is venture-backed, having raised more than $6.5 million cumulatively from individual investors including Citadel founder Ken Griffin and former Walgreens executive Stewart Wasson, with disclosed funding rounds in 2015, 2019, and 2020. Headcount sits in the 11–50 range, with a three-person engineering team that maintains HIPAA expertise. The company competes in the global teledermatology market, valued at $16.71 billion in 2025 with a projected 16.72% CAGR through 2034, and the AI-powered tele-dermatology triage segment ($2.8 billion in 2025, projected to $9.4 billion by 2034).

SkinIO firmographics

Firmographics
Name
SkinIO
Legal name
SkinIO, Inc.
Website
https://skinio.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
SkinIO is a Chicago-based health technology company offering AI-powered smartphone skin cancer screening with board-certified dermatologist review, serving individual consumers via a $239 mobile app and enterprises (employers, health systems, unions) as a workplace wellness benefit.
Ownership category
akta.pro rank

SkinIO industry classification

Industry
Product category
Teledermatology Software
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
akta.pro industry
PRIMARYHLALAGAA
Dermatology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAKACAA
General & Medical Dermatology

Keywords

  • Skin cancer screening
  • Teledermatology platform
  • AI skin imaging
  • Employee wellness benefits
  • Digital skin health record

Where SkinIO is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices1 record

Markets served

SkinIO business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Direct-to-Consumer Screening: Individual consumers purchase one-time skin cancer screenings through the SkinIO app for $239. Each screening includes a full-body photo capture, dermatologist review, and results delivered in 2-3 days.
  2. Enterprise/B2B Employee Benefits: SkinIO sells its screening platform as an employee health benefit to large employers, unions, and health systems (such as MetroHealth System). B2B contracts likely involve per-employee/per-screening pricing or subscription arrangements.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goOne-Time Skin Cancer Screening - $239

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

SkinIO product offering

Product offering

Core offering

SkinIO provides an AI-powered smartphone-based skin cancer screening platform that guides users through a 10-minute full-body photo capture, uploads images to a HIPAA-compliant cloud for review by board-certified dermatologists, and delivers medical recommendations in 2-3 days. The platform operates a direct-to-consumer mobile app at $239 per screening and also offers enterprise solutions for employers, unions, health systems, and clinicians, including a Connection to Care service that fast-tracks patients needing follow-up to in-network dermatologists within 2-3 weeks.

Product overview

SkinIO is a health technology company offering an AI-powered skin cancer screening platform. The core offering consists of the SkinIO mobile app for consumer skin screening and the Connection to Care service for dermatologist referrals. The platform enables 10-minute smartphone-based full-body skin scans with board-certified dermatologist review delivered within 2-3 days. Enterprise offerings include dedicated solutions for employers, health systems, unions, and clinicians. The dermatologist-facing platform provides tools for image review, spot annotation, and longitudinal tracking. Priced at $239 per screening (with promotional pricing at $189 available).

Differentiator

Problem solved

Functional benefit

Products and services

  • SkinIO Mobile App Consumer-facing mobile application available on iOS and Android that enables individuals to complete a full-body skin cancer screening from home in 10 minutes using their smartphone. The app guides users through the photo-taking process and uploads images for board-certified dermatologist review.
  • Connection to Care Care coordination service that fast-tracks users whose SkinIO scan flags concerning findings to in-network dermatologists for in-person follow-up, with appointments typically scheduled within 2-3 weeks.
  • SkinIO for Employers Enterprise offering that provides large employers with SkinIO's skin cancer screening technology as an employee health benefit, aimed at controlling healthcare costs and improving workforce health outcomes through early detection.
  • SkinIO for Health Systems Healthcare system integration that enables hospitals and health systems to offer SkinIO's skin cancer screening technology to their patient populations as part of integrated care pathways.
  • SkinIO for Clinicians Dermatologist-facing clinical platform that allows clinicians to review patient-submitted skin images, annotate spots with notes and dermoscopic images, mark them as new, changed, or suspicious, and track changes over time across visits.
  • SkinIO for Unions Union benefit offering that provides union members with access to SkinIO's skin cancer screening services as part of their member health benefits package.
  • SkinIO Web Application Web-based platform that allows users to access their SkinIO accounts, review screening results, and manage their longitudinal digital skin health records through a browser.

Quantifiable outcome

  • Detects changes in skin down to 1mm
  • +4 more outcomes

Companies that use SkinIO

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles4 records

SkinIO technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

SkinIO partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • MSK DirectcoreGTM or Marketing Partner · 6 May 2025SkinIO was featured in the Innovator Spotlight at MSK Direct Benefits Leaders' Summit in New York City, showcasing AI-powered skin cancer screening platform to benefits leaders from major employers.
  • City of DreamsminorOthers · 14 April 2025San Francisco-based nonprofit dedicated to empowering youth in underserved neighborhoods. SkinIO donated to support their mission, reflecting broader commitment to community wellbeing.
  • ACP (Advanced Career Strategies)coreGTM or Marketing Partner · 2 March 2025SkinIO participated in the ACP Employee Health & Wellness Conference, an exclusive event connecting top benefits executives with innovative healthcare solution providers.
  • Smart Health Innovation LabcoreStrategic or Co-development PartnerSmart Health Innovation Lab partnered with SkinIO to bring virtual skin cancer screenings to Lancaster County. SkinIO provides at-home and on-site skin cancer screenings to employees of Signature Custom Cabinetry and Aspire Ventures, an investor/founder of the Innovation Lab.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

SkinIO competitors and assessment

Company assessment

Direct peers

  • SkinVision: SkinVision is an Amsterdam-based AI-powered skin cancer detection app with regulatory clearances (CE-marked, TGA-approved). It is the closest direct competitor to SkinIO, offering smartphone-based skin lesion risk assessment with teledermatology follow-up pathways.
  • Miiskin: Miiskin offers a smartphone-based mole and skin tracking app with AI-assisted photo comparison and partner dermatologist review. It serves a similar consumer self-monitoring niche and shares SkinIO's longitudinal skin-photo record feature.
  • DermaSensor: DermaSensor is an FDA-cleared (2024) handheld device that uses AI and spectroscopy to evaluate skin lesions for primary care clinicians. It addresses the same skin cancer early-detection problem as SkinIO but through a clinical device rather than a smartphone app, making it a direct competitor for clinician and health system channels.
  • FotoFinder: FotoFinder ( FotoFinder Systems GmbH) is a German specialist in total body photography and AI-assisted mole mapping for dermatology clinics. It competes with SkinIO for dermatologist and health system accounts that need longitudinal skin imaging, though its deployment model is hardware-based clinical installs rather than consumer smartphones.
  • MetaOptima: MetaOptima built the DermEngine platform for dermatology imaging and AI skin lesion analysis, used by clinics and teledermatology services. It overlaps with SkinIO's clinician and health system offerings and is a credible direct competitor in AI dermatology decision support.
  • First Derm: First Derm operates an asynchronous teledermatology platform connecting users to board-certified dermatologists for image-based consultations. It targets a similar consumer and enterprise use case as SkinIO but uses a per-consultation ticket model rather than an annual screening subscription.

Broad incumbents

  • Canfield Scientific: Canfield Scientific is a long-established US leader in dermatology imaging systems, including VECTRA total body photography and DermaGraphix software. It sells primarily to dermatology practices and competes with SkinIO at the clinician-facing end of the market with significantly more capital and installed base.
  • Teladoc Health: Teladoc is the largest US telehealth platform with broad specialty coverage and enterprise contracts that easily absorb dermatology. As a broad incumbent, it could bundle or build a competing skin screening offering, putting enterprise channel pressure on SkinIO's go-to-market.
  • Amwell: Amwell is an enterprise telehealth platform serving health systems and health plans with multi-specialty virtual care. It competes with SkinIO at the health system channel level and has the capital to acquire or build a teledermatology offering at scale.

Emerging players

  • MoleScope: MoleScope by MetaOptima offers a smartphone-attachable dermatoscope with the DermEngine app for mole tracking and teledermatology. It overlaps meaningfully with SkinIO on consumer smartphone-based skin monitoring while adding a hardware component that targets more clinical mole-mapping use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

SkinIO social profiles

Digital presence

SkinIO compliance and trust

Trust signal

Compliance3 records

SkinIO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SkinIO leadership team

Management profile

Number of profiles

Profiles5 records

SkinIO funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SkinIO M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SkinIO

What does SkinIO do?

SkinIO provides an AI-powered smartphone-based skin cancer screening platform that guides users through a 10-minute full-body photo capture, uploads images to a HIPAA-compliant cloud for review by board-certified dermatologists, and delivers medical recommendations in 2-3 days. The platform operates a direct-to-consumer mobile app at $239 per screening and also offers enterprise solutions for employers, unions, health systems, and clinicians, including a Connection to Care service that fast-tracks patients needing follow-up to in-network dermatologists within 2-3 weeks.

Is SkinIO a public or private company?

SkinIO is a private company. It is classified as venture growth investor backed and is currently operating.

When was SkinIO founded?

SkinIO was founded in 2015. It employs 11 to 50 people.

Where is SkinIO based?

SkinIO is headquartered in Chicago, United States, in the North America region.

How does SkinIO make money?

Two revenue lines are on record. Direct-to-Consumer Screening is the primary driver. The others are enterprise/B2B Employee Benefits.

Who are SkinIO's main competitors?

Direct peers on record are SkinVision, Miiskin, DermaSensor, FotoFinder, MetaOptima and First Derm. Broad incumbents are Canfield Scientific, Teladoc Health and Amwell. MoleScope is listed as an emerging player.

Does SkinIO have an API?

No public API is recorded for SkinIO.

What industry is SkinIO in?

SkinIO's product category is Teledermatology Software. Its primary akta.pro industry code is HLALAGAA, Dermatology Telemedicine Platforms, with a secondary code of HLAKACAA, General & Medical Dermatology. Its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireSkinIO Featured in Breakthroughs™ PSA Highlighting AI-Enhanced Skin Imaging and Rapid Connection to Dermatology CareSkinIO is featured in a Breakthroughs public-service announcement highlighting its AI-enhanced skin imaging and rapid connection to dermatology care. The PSA promotes earlier skin cancer detection and accessible follow-up, with CEO Steve Bonner noting the series explains how earlier detection and swift therapy can reduce advanced-stage skin cancer burden.AJMCHow SkinIO's Full Body Scan Caught Melanoma: Steve BonnerThe article discusses SkinIO's innovative Full Body Scan technology that has successfully identified cases of melanoma. This development highlights SkinIO's commitment to improving skin cancer detection and prevention. The technology aims to enhance early diagnosis and treatment options for patients.PR NewswireColor Health Announces At-Home and At-Work Cancer Screening Expansion with SkinIO and BexaColor Health announced partnerships with SkinIO and Bexa to integrate their skin and breast cancer screening technologies into its Virtual Cancer Clinic platform. The collaboration aims to expand access to early detection by offering at-home smartphone screenings via SkinIO and onsite workplace exams via Bexa across the United States. These new services are scheduled to launch for Color's employer and union customers on September 1, 2024.HIT ConsultantColor Health Expands Cancer Screening with SkinIO and Bexa PartnershipsColor Health announced partnerships with SkinIO and Bexa to integrate skin and breast cancer screening into its Virtual Cancer Clinic. The services, including AI-powered full-body skin exams and pain-free breast exams, will be available to customers starting September 1, 2024.Harvard GazetteAlumni profile: Kyoko Crawford, S.B. '04Kyoko Crawford co-founded SkinIO in 2014 to develop a smartphone application that utilizes machine learning to detect and track skin cancer early. The company adjusted its market focus during the pandemic by targeting industries at higher risk for skin cancer, such as airlines and construction, as many dermatology practices closed. SkinIO has adapted its business model over the years, emphasizing the importance of understanding healthcare market dynamics for long-term success.Stanford University School of EngineeringMobile app helps detect skin cancer in older patientsOlder adults and residents in assisted-care facilities faced a significant drop in skin cancer diagnoses during the COVID-19 pandemic due to reduced clinic visits, prompting a study using the SkinIO mobile app to monitor skin health. The app allows users to capture images of potentially cancerous lesions, which are then reviewed by dermatologists; the pilot study identified skin cancers in three out of 27 participants. As the pandemic continues, there is potential for broader use of the app to enhance access to dermatological care for vulnerable populations.BitlyMATTER Startup Spotlight: SkinIOSkinIO, a startup backed by MATTER, is expanding its AI-driven skin cancer screening platform to employer groups, health systems, and municipalities to improve access to dermatological care. The company utilizes smartphone-based full-body photography and AI algorithms to track skin lesions and triage patients to dermatologists, addressing the shortage of specialists in the U.S. market.trib.alMeet SkinIO, the startup that is bringing virtual specialty care to dermatologyChicago-based startup SkinIO has joined the Smart Health Innovation Lab, a joint venture between Aspire Ventures, Capital Blue Cross, Clio Health, and Penn Medicine Lancaster General Health. The company's AI-powered app enables early detection of skin cancer by analyzing smartphone photos for review by board-certified dermatologists at a lower cost than traditional visits.PrwebSkinIO Launches Teledermatology App to Combat Poor Photo Quality Amid COVID-19 Telemedicine SurgeSkinIO has launched SkinIO Teledermatology, a digital platform aimed at improving the quality of dermatological care during the COVID-19 pandemic. The app guides patients in capturing high-quality images for remote consultations, enhancing the capabilities of dermatologists. This development addresses the increased demand for virtual healthcare solutions amidst the ongoing global health crisis.GlobeNewswireNextech and SkinIO Partner to Improve Dermatologist WorkflowNextech Systems announced a partnership with SkinIO to integrate full-body imaging into dermatology practices. The integration allows providers to use SkinIO's mobile app-guided imaging within their EMR workflow. SkinIO's system enables standardized photography and mole-mapping in 5-10 minutes.